Literature DB >> 12858447

Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus.

Mart Mannik1, Cynthia E Merrill, Louis D Stamps, Mark H Wener.   

Abstract

OBJECTIVE: To determine the specific antibodies present in glomerular immune deposits in patients with systemic lupus erythematosus (SLE).
METHODS: Kidney tissue was obtained at autopsy and stored frozen until used. Glomeruli were isolated from the renal cortex, sonicated, and the glomerular basement membrane fragments were extracted with a pH 2.5 buffer or 6 M guanidine hydrochloride. The latter method provided a higher yield and was used in most of the 23 specimens studied. The extracted IgG was quantified by a capture assay using an ELISA with chemiluminescence. IgG antibodies to 14 different antigens were quantified by the same type of assay. The enrichment of antibodies in the extracts was determined in comparison to the initial supernatant of glomeruli that served as a serum surrogate.
RESULTS: Antibodies to dsDNA, the collagen-like region of C1q, Sm, SSA, SSB, and chromatin were enriched in glomerular extracts, mainly from patients with proliferative lupus glomerulonephritis. The IgG binding to histones resulted from the presence of immune or non-immune aggregates of IgG. In some specimens all 6 of the above-listed antibodies were enriched. In one specimen antibodies to myeloperoxidase were enriched. Antibodies to cathepsin G, lactoferrin, and beta2-glycoprotein I were not detected. Antibodies to Epstein-Barr viral capsid antigen and nuclear antigen 1 and antibodies to tetanus toxoid were detected in the serum surrogate, but were not enriched in extracts of glomerular basement membrane fragments.
CONCLUSION: Autoantibodies with multiple different specificities form the immune deposits in glomeruli of patients with SLE, including antibodies to dsDNA, Sm, SSA, SSB, the collagen-like region of C1q, and chromatin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12858447

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  47 in total

1.  Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens.

Authors:  Maurizio Bruschi; Maricla Galetti; Renato Alberto Sinico; Gabriella Moroni; Alice Bonanni; Antonella Radice; Angela Tincani; Federico Pratesi; Paola Migliorini; Corrado Murtas; Franco Franceschini; Barbara Trezzi; Francesca Brunini; Rita Gatti; Regina Tardanico; Giancarlo Barbano; Giorgio Piaggio; Piergiorgio Messa; Pietro Ravani; Francesco Scolari; Giovanni Candiano; Alberto Martini; Landino Allegri; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2014-11-14       Impact factor: 10.121

2.  Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays.

Authors:  Quan-Zhen Li; Quan Li Zhen; Chun Xie; Tianfu Wu; Meggan Mackay; Cynthia Aranow; Chaim Putterman; Chandra Mohan
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 3.  Changing the concepts of immune-mediated glomerular diseases through proteomics.

Authors:  Dawn J Caster; Liliane Hobeika; Jon B Klein; David W Powell; Kenneth R McLeish
Journal:  Proteomics Clin Appl       Date:  2015-06-17       Impact factor: 3.494

4.  A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus.

Authors:  Vaidehi R Chowdhary; Chao Dai; Ashenafi Y Tilahun; Julie A Hanson; Michele K Smart; Joseph P Grande; Govindarajan Rajagopalan; Shu-Man Fu; Chella S David
Journal:  J Immunol       Date:  2015-10-16       Impact factor: 5.422

5.  Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis.

Authors:  Dawn J Caster; Erik A Korte; Michael L Merchant; Jon B Klein; Daniel W Wilkey; Brad H Rovin; Dan J Birmingham; John B Harley; Beth L Cobb; Bahram Namjou; Kenneth R McLeish; David W Powell
Journal:  Proteomics Clin Appl       Date:  2015-06-12       Impact factor: 3.494

6.  Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort.

Authors:  Mariangelí Arroyo-Ávila; Yesenia Santiago-Casas; Gerald McGwin; Ryan S Cantor; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Robert P Kimberly; Graciela S Alarcón; Luis M Vilá; Elizabeth E Brown
Journal:  Clin Rheumatol       Date:  2015-04-22       Impact factor: 2.980

7.  The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.

Authors:  Jonathan Sitrin; Eric Suto; Arthur Wuster; Jeffrey Eastham-Anderson; Jeong M Kim; Cary D Austin; Wyne P Lee; Timothy W Behrens
Journal:  J Immunol       Date:  2017-07-10       Impact factor: 5.422

8.  TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.

Authors:  Tanvi Arkatkar; Holly M Jacobs; Samuel W Du; Quan-Zhen Li; Kelly L Hudkins; Charles E Alpers; David J Rawlings; Shaun W Jackson
Journal:  Kidney Int       Date:  2018-06-12       Impact factor: 10.612

Review 9.  The Role of Anti-DNA Antibodies in the Development of Lupus Nephritis: A Complementary, or Alternative, Viewpoint?

Authors:  Beatrice Goilav; Chaim Putterman
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

10.  Male gender results in more severe lupus nephritis.

Authors:  Jozélio Freire de Carvalho; Ana Patrícia do Nascimento; Leonardo A Testagrossa; Rui Toledo Barros; Eloísa Bonfá
Journal:  Rheumatol Int       Date:  2009-09-27       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.